TYMSOS and non-small cell lung carcinoma: Two axes, TYMSOS/hsa-miR-101-3p/CEP55 and TYMSOS/hsa-miR-195-5p/CHEK1, were validated as key pathways in the development and progression of NSCLC and its histological subtypes [60].